Pharmaceuticals
Even Small Financial Incentives Influence Prescribing Habits
Reported receipt of any non-research support from pharmaceutical manufacturers, regardless of amount, was associated with an almost doubled probability of a prostaglandin drug Rx.
08/02/2022
Study: Two-thirds of Patients Have Skin Reactions to Topical Ophthalmic Meds
Active ingredients, especially aminoglycoside antibiotics, were the main cause.
07/19/2022
Antibiotic Resistance Remains Prevalent in Ocular Staphylococcal Infections
Newest ARMOR study data helps inform clinicians when choosing a therapy to pursue in affected patients.
05/11/2022
Managing Pediatric Ocular Pathology
Safe treatment of these patients requires a comprehensive understanding of available therapeutics.
03/15/2022
Update your Glaucoma Prescribing Protocols
Treatment options continue to evolve, with new meds and methods to consider.
03/15/2022
Hearing Loss a Possible Complication of Thyroid Eye Disease Drug
A small case series of teprotumumab-treated patients experienced auditory changes and other otologic symptoms.
03/08/2022
Teprotumumab Promising as Treatment For Proptosis, Diplopia
Compared with placebo and methylprednisolone, the drug was associated with greater symptomatic improvement.
02/25/2022
Oral CAIs More Safe Than Many Believe
The risk of adverse events was comparable to that of topical formulations, study finds.
02/01/2022
First Presbyopia Eye Drop Approved
The pilocarpine agent improves near and intermediate acuity, according to manufacturer Allergan.
10/29/2021
TNS Safe Treatment for Ocular Pain
Study suggests three- to six-month use of a trigeminal neurostimulator decreased eye pain, light and wind sensitivity, and burning sensations.
06/01/2021
